Device Dossier

Acquired genetic alteration IVDs

Device Dossier for Acquired genetic alteration IVDs (CT929 - Acquired genetic alteration IVDs, Class 3, sponsor Sysmex). ARTG record, intended purpose,…

Intended purpose

IVDs that are intended to be used in genetic testing to provide information about acquired genetic alterations, which may include chromosomal alterations, mutations and/or alterations in gene expression, and which may be used to characterise haematological or solid tumour malignancies and/or provide prognostic information. These products are intended for use as an adjunct to classic cytogenetics and not as independent tests or assays.

TGA Public Summary